Results 101 to 110 of about 47,575 (169)

Effects of a personalized exercise program on physical function in older patients with rheumatoid arthritis at high risk of sarcopenia: results of a randomized controlled trial. [PDF]

Arthritis Res Ther
Torii M, Onishi A, Uozumi R, Hidaka Y, Onizawa H, Fujii T, Murata K, Murakami K, Tanaka M, Oshima Y, Tanaka H, Urai Y, Tanigawa K, Yoshitomi H, Tsuji H, Shirakashi M, Hiwa R, Nakashima R, Nin K, Kinoshita A, Matsuda S, Morinobu A, Arai H, Hashimoto M.   +23 more
europepmc   +1 more source

Survival outcomes of ERBB2-amplified metastatic colorectal cancer treated with first-line chemotherapy. [PDF]

Br J Cancer
Matsubara Y, Bando H, Nakamura Y, Misumi T, Ng D, Tajima E, Pittell H, Ohtsu A, Yoshino T.   +8 more
europepmc   +1 more source

A REVIEW OF INFLUENCE OF THE GENERIC DRUG USER FEES ACT UPON THE EXPORT FROM THE INDIAN PHARMACEUTICAL INDUSTRY

International Research Journal Of Pharmacy, 2018
openaire   +1 more source

Gut microbiome-driven modulation of the tumor immune microenvironment optimizes dual checkpoint blockade in advanced non-small-cell lung cancer. [PDF]

ESMO Open
Katayama Y, Fukuda A, Inoue R, Kawachi H, Sawada R, Harada T, Yoshimura A, Okada A, Shiotsu S, Chihara Y, Takemura Y, Yamada T, Nishioka N, Iwasaku M, Tokuda S, Takagi T, Kumagai S, Koyama S, Takayama K, Yamada T.   +19 more
europepmc   +1 more source

Study protocol of a randomized controlled phase II trial comparing nivolumab, ipilimumab plus radiotherapy versus nivolumab plus ipilimumab for advanced or recurrent esophageal cancer: Japan Clinical Oncology Group study JCOG2311 (ART NOUVEAU). [PDF]

BMC Cancer
Sakanaka K, Sasaki K, Tsushima T, Machida R, Hamai Y, Watanabe A, Kawabata K, Matsuda S, Kato K, Fukuda H, Takeuchi H, Japan Esophageal Oncology Group of the Japan Clinical Oncology Group.   +11 more
europepmc   +1 more source

Access fees in a hospital library: a program for pharmaceutical company representatives.

Bulletin of the Medical Library Association, 1987
openaire   +1 more source

Proton-pump inhibitors and palbociclib or abemaciclib in endocrine-sensitive breast cancer treatment. [PDF]

Sci Rep
Takada S, Takahashi K, Uozumi R, Mukohara T, Hayashida T, Iwabe M, Iihara H, Kusuhara-Mamishin K, Tahatsu K, Kitagawa Y, Tsuchiya M, Kitahora M, Umehara K, Nagayama A, Kosaka S, Asano-Niwa Y, Watanabe K, Seki T, Ohnuki K, Futamura M, Kawazoe H, Nakamura T.   +21 more
europepmc   +1 more source

Effect of prior therapy on the clinical activity of imetelstat in patients with transfusion-dependent, ESA-relapsed or -refractory/-ineligible LR-MDS. [PDF]

Blood Cancer J
Komrokji RS, Santini V, Zeidan AM, Sekeres MA, Fenaux P, Raza A, Mittelman M, Thépot S, Buckstein R, Germing U, Madanat YF, Díez-Campelo M, Valcárcel D, Jonášová A, Dougherty S, Shah S, Xia Q, Sun L, Navada S, Feller F, Savona MR, Platzbecker U.   +21 more
europepmc   +1 more source

Randomized crossover comparison of two teriparatide self-injection regimens for primary osteoporosis: final report of the Japanese Osteoporosis Intervention Trial 06 (JOINT-06). [PDF]

J Bone Miner Metab
Tanaka S, Uemura Y, Tanaka S, Takeuchi Y, Endo N, Takada J, Ikeda S, Iwamoto J, Okimoto N, Soen S.   +9 more
europepmc   +1 more source